Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
NAV2024-05-13 | Chg.+15.9500 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
2,027.4399EUR | +0.79% | reinvestment | Equity Worldwide | Candriam ▶ |
GlobeNewswire
2:15 PM
Gratus Capital Partners with iCapital® to Launch Hedge Fund Investing Opportunities to Wealth Manage...
GlobeNewswire
12:55 PM
YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs
GlobeNewswire
12:15 AM
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2024